Industry reports
Editor highlights

Pathology

Summary

Table of Contents

Data Series

  • Publication date: April 2013
  • Report size: 222 pages
Keywords : T-cell lymphoma, Anaplastic large cell lymphoma, lymphoma

This report provides data on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell Lymphomas. 'T-Cell Lymphomas - Pipeline Review, H1 2012' is built using data and information sourced from Global Industries Direct’s proprietary databases, Firms /University websites, SEC filings, i...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Pathology Industry in the United States : Latest Reports

Trypanosomiasis - Pipeline Review, H2 2013

Trypanosomiasis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Trypanosomiasis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

Chronic Urticaria Or Hives - Pipeline Review, H2 2013

Chronic Urticaria Or Hives - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Chronic Urticaria Or Hives - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Chronic Urticaria Or Hives - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

Hemoglobinopathies - Pipeline Review, H2 2013

Hemoglobinopathies - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Hemoglobinopathies - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hemoglobinopathies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

Rubella - Pipeline Review, H2 2013

December 2013 $ 2 000

Pathology Industry in the United States : Latest Downloads

Company Report: Cancer for Year 2014

  • Company report
  • April 2014
  • 2 pages

... Personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class ...

Company Report: Pathology for Year 2014

  • Company report
  • April 2014
  • 7 pages

Company Report: Pathology for Year 2014

  • Company report
  • April 2014
  • 6 pages

... For ampyra in stroke, the adaptive design of the phase 2/3 trial should allow acorda to take an interim look at efficacy as measured by 2-min walk distance as well as a scaled efficacy measurement similar ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.